Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900023027Phase 4Recruiting
Phase 4, randomised, open-label trial of lidocaine in respiratory complication (2 arms), sponsored by Xuzhou Medical University. Primary endpoint: Perioperative respiratory adverse events. Started Mar 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900023027.